-
2
-
-
0037639734
-
Genetically engineered T cells as adoptive immunotherapy of cancer
-
Giaccone R, Schilsky R, Sondel P, eds. Annual 20. UK: Elsevier Science
-
Ma Q, Gonzalo-Daganzo RM, Junghans RP. Genetically engineered T cells as adoptive immunotherapy of cancer. In: Giaccone R, Schilsky R, Sondel P, eds. Cancer Chemotherapy and Biological Response Modifers. Annual 20. UK: Elsevier Science; 2002: 315-341.
-
(2002)
Cancer Chemotherapy and Biological Response Modifers
, pp. 315-341
-
-
Ma, Q.1
Gonzalo-Daganzo, R.M.2
Junghans, R.P.3
-
3
-
-
0037264471
-
Targeting tumours with genetically enhanced T lymphocytes
-
Sadelain M, Riviere I, Brentjens R. Targeting tumours with genetically enhanced T lymphocytes. Nat Rev Cancer. 2003;3:35-45.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 35-45
-
-
Sadelain, M.1
Riviere, I.2
Brentjens, R.3
-
4
-
-
0034034214
-
Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor
-
Beecham EJ, Ortiz-Pujols S, Junghans RP. Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor. J Immunother. 2000;23:332-343.
-
(2000)
J Immunother
, vol.23
, pp. 332-343
-
-
Beecham, E.J.1
Ortiz-Pujols, S.2
Junghans, R.P.3
-
5
-
-
0033385052
-
Bypassing immunization: Optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA
-
Nolan KF, Yun CO, Akamatsu Y, et al. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA. Clin Cancer Res. 1999;5:3928-3941.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 3928-3941
-
-
Nolan, K.F.1
Yun, C.O.2
Akamatsu, Y.3
-
6
-
-
0026643255
-
Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen
-
Nap M, Hammarstrom ML, Bormer O, et al. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. Cancer Res. 1992;52:2329-2339.
-
(1992)
Cancer Res
, vol.52
, pp. 2329-2339
-
-
Nap, M.1
Hammarstrom, M.L.2
Bormer, O.3
-
7
-
-
0000696984
-
Cancer markers
-
DeVita VT, Hellman S, Rosenberg SA, eds. Philadelphia: J. B. Lippincott Co.
-
Schwartz MK. Cancer markers. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: J. B. Lippincott Co.; 1993: 531-542.
-
(1993)
Cancer: Principles and Practice of Oncology
, pp. 531-542
-
-
Schwartz, M.K.1
-
8
-
-
0031963294
-
Cancer statistics, 1998
-
Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6-29.
-
(1998)
CA Cancer J Clin
, vol.48
, pp. 6-29
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
-
9
-
-
0034526330
-
Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors
-
Yun CO, Nolan KF, Beecham EJ, et al. Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors. Neoplasia. 2000;2: 449-459.
-
(2000)
Neoplasia
, vol.2
, pp. 449-459
-
-
Yun, C.O.1
Nolan, K.F.2
Beecham, E.J.3
-
10
-
-
0034634865
-
Generation of gene-modified T cells reactive against the angiogenic kinase insert domain-containing receptor (KDR) found on tumor vasculature
-
Kershaw MH, Westwood JA, Zhu Z, et al. Generation of gene-modified T cells reactive against the angiogenic kinase insert domain-containing receptor (KDR) found on tumor vasculature. Hum Gene Ther. 2000;11:2445-2452.
-
(2000)
Hum Gene Ther
, vol.11
, pp. 2445-2452
-
-
Kershaw, M.H.1
Westwood, J.A.2
Zhu, Z.3
-
11
-
-
0030267660
-
In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation
-
Harvill ET, Fleming JM, Morrison SL. In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation. J Immunol. 1996;157:3165-3170.
-
(1996)
J Immunol
, vol.157
, pp. 3165-3170
-
-
Harvill, E.T.1
Fleming, J.M.2
Morrison, S.L.3
-
12
-
-
0021010719
-
Selection of lectin-resistant mutants of animal cells
-
Stanley P. Selection of lectin-resistant mutants of animal cells. Methods Enzymol. 1983;96:157-184.
-
(1983)
Methods Enzymol
, vol.96
, pp. 157-184
-
-
Stanley, P.1
-
13
-
-
0018374319
-
Characterization of cell lines showing growth control isolated from both the wild type and a leucyl-tRNA synthetase mutant of Chinese hamster ovary cells
-
Pollard JW, Stanners CP. Characterization of cell lines showing growth control isolated from both the wild type and a leucyl-tRNA synthetase mutant of Chinese hamster ovary cells. J Cell Physiol. 1979;98:571-585.
-
(1979)
J Cell Physiol
, vol.98
, pp. 571-585
-
-
Pollard, J.W.1
Stanners, C.P.2
-
14
-
-
0038109905
-
The adhesion and differentiation-inhibitory activities of the immunoglobulin superfamily member, carcinoembryonic antigen, can be independently blocked
-
Taheri M, Saragovi HU, Stanners CP. The adhesion and differentiation- inhibitory activities of the immunoglobulin superfamily member, carcinoembryonic antigen, can be independently blocked. J Biol Chem. 2003;278:14632-14639.
-
(2003)
J Biol Chem
, vol.278
, pp. 14632-14639
-
-
Taheri, M.1
Saragovi, H.U.2
Stanners, C.P.3
-
15
-
-
0033677159
-
Coupling CD28 costimulation to immunoglobulin T-cell receptor molecules: The dynamics of T-cell proliferation and death
-
Beecham EJ, Ma Q, Ripley R, et al. Coupling CD28 costimulation to immunoglobulin T-cell receptor molecules: the dynamics of T-cell proliferation and death. J Immunother. 2000;23:631-642.
-
(2000)
J Immunother
, vol.23
, pp. 631-642
-
-
Beecham, E.J.1
Ma, Q.2
Ripley, R.3
-
16
-
-
0023180812
-
The carcinoembryonic antigen (CEA) contains multiple immunoglobulin-like domains
-
Oikawa S, Imajo S, Noguchi T, et al. The carcinoembryonic antigen (CEA) contains multiple immunoglobulin-like domains. Biochem Biophys Res Commun. 1987;144:634-642.
-
(1987)
Biochem Biophys Res Commun
, vol.144
, pp. 634-642
-
-
Oikawa, S.1
Imajo, S.2
Noguchi, T.3
-
17
-
-
0023177138
-
Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen
-
Beauchemin N, Benchimol S, Cournoyer D, et al. Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol. 1987;7:3221-3230.
-
(1987)
Mol Cell Biol.
, vol.7
, pp. 3221-3230
-
-
Beauchemin, N.1
Benchimol, S.2
Cournoyer, D.3
-
18
-
-
0023114390
-
Sequence analysis of carcinoembryonic antigen: Identification of glycosylation sites and homology with the immunoalobulin supergene family
-
Paxton RJ, Mooser G, Pande H, et al. Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoalobulin supergene family. Proc Natl Acad Sci USA. 1987;84:920-924.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 920-924
-
-
Paxton, R.J.1
Mooser, G.2
Pande, H.3
-
19
-
-
0023147934
-
Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence
-
Oikawa S, Nakazato H, Kosaki G. Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem Biophys Res Commun. 1987;142:511-518.
-
(1987)
Biochem Biophys Res Commun
, vol.142
, pp. 511-518
-
-
Oikawa, S.1
Nakazato, H.2
Kosaki, G.3
-
20
-
-
0023723045
-
Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: Identification of the ethanolamine linkage site
-
Hefta SA, Hefta LJ, Lee TD, et al. Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: identification of the ethanolamine linkage site. Proc Natl Acad Sci USA. 1988;85:4648-4652.
-
(1988)
Proc Natl Acad Sci USA
, vol.85
, pp. 4648-4652
-
-
Hefta, S.A.1
Hefta, L.J.2
Lee, T.D.3
-
22
-
-
0027198722
-
Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen
-
Hansen HJ, Goldenberg DM, Newman ES, et al. Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer. 1993;71: 3478-3485.
-
(1993)
Cancer
, vol.71
, pp. 3478-3485
-
-
Hansen, H.J.1
Goldenberg, D.M.2
Newman, E.S.3
-
23
-
-
0036042603
-
Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer
-
Gillies SD, Lan Y, Brunkhorst B, et al. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer. Cancer Immunol Immunother. 2002;51:449-460.
-
(2002)
Cancer Immunol Immunother
, vol.51
, pp. 449-460
-
-
Gillies, S.D.1
Lan, Y.2
Brunkhorst, B.3
-
24
-
-
0025190073
-
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens
-
Sharkey RM, Gold DV, Aninipot R, et al. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens. Cancer Res. 1990;50:828s-834s.
-
(1990)
Cancer Res
, vol.50
-
-
Sharkey, R.M.1
Gold, D.V.2
Aninipot, R.3
-
25
-
-
0031950733
-
Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anticarcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer
-
Juweid M, Sharkey RM, Swayne LC, et al. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anticarcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. J Nucl Med. 1998;39:34-42.
-
(1998)
J Nucl Med
, vol.39
, pp. 34-42
-
-
Juweid, M.1
Sharkey, R.M.2
Swayne, L.C.3
-
26
-
-
0036018888
-
Phase I radioimmunotherapy trial with iodine-131 - Labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer
-
Hajjar G, Sharkey RM, Burton J, et al. Phase I radioimmunotherapy trial with iodine-131 - labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer. Clin Colorectal Cancer. 2002;2:31-42.
-
(2002)
Clin Colorectal Cancer
, vol.2
, pp. 31-42
-
-
Hajjar, G.1
Sharkey, R.M.2
Burton, J.3
-
27
-
-
0032741274
-
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study
-
Behr TM, Salib AL, Liersch T, et al. Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study. Clin Cancer Res. 1999;5:3232s-3242s.
-
(1999)
Clin Cancer Res
, vol.5
-
-
Behr, T.M.1
Salib, A.L.2
Liersch, T.3
-
28
-
-
0031440647
-
Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies
-
Juweid M, Sharkey RM, Swayne LC, et al. Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies. Surgery. 1997;122:1156-1165.
-
(1997)
Surgery
, vol.122
, pp. 1156-1165
-
-
Juweid, M.1
Sharkey, R.M.2
Swayne, L.C.3
-
29
-
-
0033561012
-
Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma
-
Juweid ME, Hajjar G, Swayne LC, et al. Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma. Cancer. 1999;85:1828-1842.
-
(1999)
Cancer
, vol.85
, pp. 1828-1842
-
-
Juweid, M.E.1
Hajjar, G.2
Swayne, L.C.3
-
30
-
-
0033984384
-
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR
-
Juweid ME, Hajjar G, Stein R, et al. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR. J Nucl Med. 2000;41:93-103.
-
(2000)
J Nucl Med
, vol.41
, pp. 93-103
-
-
Juweid, M.E.1
Hajjar, G.2
Stein, R.3
-
31
-
-
0031441352
-
Prospects of radioimmunotherapy in epithelial ovarian cancer: Results with iodine-131-labeled murine and humanized MN-14 anticarcinoembryonic antigen monoclonal antibodies
-
Juweid M, Swayne LC, Sharkey RM, et al. Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anticarcinoembryonic antigen monoclonal antibodies. Gynecol Oncol. 1997;67:259-271.
-
(1997)
Gynecol Oncol
, vol.67
, pp. 259-271
-
-
Juweid, M.1
Swayne, L.C.2
Sharkey, R.M.3
-
32
-
-
0028304484
-
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2
-
Schwartzentruber DJ, Hom SS, Dadmarz R, et al. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2. J Clin Oncol. 1994;12:1475-1483.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1475-1483
-
-
Schwartzentruber, D.J.1
Hom, S.S.2
Dadmarz, R.3
-
33
-
-
0031884839
-
The duration of antigenic stimulation determines the fate of naive and effector T cells
-
Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 1998;8:89-95.
-
(1998)
Immunity
, vol.8
, pp. 89-95
-
-
Iezzi, G.1
Karjalainen, K.2
Lanzavecchia, A.3
|